Smile Digital Health Celebrates Dr. Shane McNamee’s Recent Achievement

Smile Digital Health
logo

TORONTO – December 14, 2022 – (Newswire.com)

Smile Digital Health, a leading health data fabric and exchange platform, is proud to announce that Dr. Shane McNamee, Senior Vice President, Strategic Growth, Smile Digital Health, has been named as a 2023 FedHealthIT100 Award Winner. 

This distinguished award honors 100 individuals recognized for driving change and advancement in the Federal Health Information Technology and Consulting Market.

Dr. McNamee has more than 15 years of experience overseeing the development and implementation of interoperability tools on various healthcare and technology teams, including large complex US Public Sector and commercial sector healthcare organizations. 

Prior to joining Smile Digital Health, Dr. McNamee served in the Department of Veterans Affairs, spending years supporting the physical and psychological issues of severely combat-wounded and combat-exposed veterans. He also led VA and DoD data interoperability success in the Joint Legacy Viewer, helping to connect patient information across the federal landscape and was responsible for Fed Health IT systems integration at Peraton as CMIO. 

This is not the first time Dr. McNamee has been recognized. In 2022, he was also a recipient of this prestigious award, showing that he continues to push towards digital transformation in the healthcare industry. He raises awareness in the community through informative articles, discussions and speaking engagements.

In the past year at Smile Digital Health, Dr. McNamee helped establish the company’s global market presence by powering product strategy, applied data to drive healthcare metrics, accelerated sales through business development, and built partnerships, alliances and distribution channels.

Along with these achievements, Dr. McNamee serves as the Executive Director for OMG® sponsored BPM+ Health Community and is a board member in IHE USA.

“We are beyond proud of our team’s thought leadership. This award is a recognition of Shane’s recent achievements and showcases those values that we, as an organization, strive towards,” said Duncan Weatherston, Chief Executive Officer, Smile Digital Health. 

FedHealthIT is a trusted content provider, connecting government and industry through their FedHealthIT magazine and website. 

“It is inspiring to see this year’s list of winners, selected by a panel of current and former government and industry leaders from across the Federal Health IT sector. The work they have contributed to the industry is immense. We look forward to seeing how these efforts impact future transformations in the field,” said Susan Sharer, Chief Executive Officer, FedHealthIT. 

The recipients were honored at the 7th Annual FedHealthIT100 Awards and Holiday Celebration on Wednesday, Dec. 7. The conference brought together senior healthcare executives from across the Federal Government and industry to focus on The Year Ahead, including the initiatives and programs that will be driving Federal Health IT in 2023.

About the FedHealthIT100

The FedHealthIT100 is an annual award honoring individuals who are making an impact, going above and beyond, driving innovation and positive outcomes, challenging conventional wisdom, and giving back to the larger HealthIT community. For further information, visit https://www.fedhealthit.com

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, health data fabric and exchange platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate, and meaningfully share health information to power digital transformation. We prepare healthcare providers, payers, researchers, and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. 

We help healthcare organizations confidently #ChooseOpenStandards with the goal of #BetterGlobalHealth. For more information, visit SmileDigitalHealth.com.

Contact Information:

Victoria Valladolid

Acting Director of Marketing

[email protected]

(877) 537-3343 x 728

Press Release Service
by
Newswire.com

Original Source:

Shane McNamee of Smile Digital Health Named 2023 FedHealthIT100 Award Recipient

DES PLAINES, Ill. – December 14, 2022 – (Newswire.com)

CIMSS has a…

New Integration Delivers 52% Cost Savings and 88% Time Savings in Computational Execution with GPU-accelerated Industry-Standard Tools

…

Award-winning company expands their U.S. warehouse with its high-quality Mini C-Arm refurbishment center.

HAUPPAUGE, N.Y. …

Two-day virtual training session will give participants the skills to identify and address ethical challenges

MALVERN, Pa. …

LAKE SAINT LOUIS, Mo. – December 13, 2022 – (Newswire.com)

As a reflecti…

AMHERST, Mass. – December 13, 2022 – (Newswire.com)

Cambridge Biotherapies, the Boston area’s preeminent mental health care clinic, announced the opening of a new location in Amherst, Massachusetts. The announcement comes with great excitement. Cambridge Biotherapies’ medical director, Dr. Dan Brenner, explains, “We’ve looked forward to expanding what we offer to Amherst for a couple of years. Amherst is a diverse, inclusive community with so many educational and cultural opportunities.”

Cambridge Biotherapies leads the way in alternative, evidence-based treatments like psychedelic therapy (ketamine-assisted psychotherapy), ketamine infusion therapy, and TMS. “These are groundbreaking treatments for depression and anxiety,” according to Brenner. “They work faster than any interventions we have developed in psychiatry thus far – they are more effective, and they are generally safer than most medications.” With rigorously researched methods, Cambridge Biotherapies has kept up with cutting-edge scientific advancements in mental health care. “We’re delighted to bring these proven therapies to the Amherst area.” Cambridge Biotherapies also offers psychiatric medication management.

At Cambridge Biotherapies, we improve the lives of people affected by mental illness.

We pursue this mission by:

• Helping patients define and achieve recovery.
• Providing the highest-quality, compassionate care in collaboration with our patients, their families when needed, and outside treaters​.
• Practicing with integrity, compassion, and discretion​.
• Using evidenced-based treatments and staying fully up-to-date with emerging research.
• Maintaining the highest ethical standards.
• Focusing on our patients’ needs and tailoring treatment to meet each individual’s needs.

About Cambridge Biotherapies,

Many people find Cambridge Biotherapies at a critical time in their life.

Cambridge Biotherapies is a treatment-to-wellness center. We use ketamine therapy, ketamine-assisted psychotherapy, TMS, and medication management to address many mental health conditions. Our service begins with a full evaluation to determine the best way to treat each patient. This may involve single or multiple treatments for an integrated approach to wellness. Our job is not done until our patients recover.

Hospitals often feel cold and impersonal, but Cambridge Biotherapies fuses the latest technology and research with a comfortable, home-like environment. Our treatments are conducted by one clinician with one patient at a time, giving you privacy and an opportunity to engage in a safe and supportive relationship.

Dr. Daniel Brenner, Medical Director: Dr. Brenner attended Harvard University and Tufts Medical School. He completed his residency in Psychiatry at Cambridge Hospital, Harvard Medical School, where he served as Chief Resident. He then served as an Attending Psychiatrist and Fellow in the Program for Psychotherapy. He was a Clinical Instructor in Psychiatry at Harvard Medical School from 2000-2010 and is a Boston Psychoanalytic Society and Institute graduate. He was board certified in Psychiatry and Neurology and has been in private practice for over 20 years.

For questions or more information on the services that Cambridge Biotherapies offers, please contact them below:

7 N Pleasant St. Suite 2C Amherst, MA 01002
Phone: (617) 803-9722
Fax: (617) 812-1680
[email protected]

Contact Information:

Brendan O’Connor

VP of Operations

[email protected]

617-803-9722

Press Release Service
by
Newswire.com

Original Source:

Cambridge Biotherapies Opening New Mental Health Treatment Center Offering Psychedelic Therapy, TMS, and More in Amherst, Massachusetts

Clarity Clinic – Mokena is currently accepting intakes and opens

Clarity Clinic Clarity Clinic Logo
MOKENA, Ill. …

EveLab Insight’s skin analysis system Eve M is designed to generate personalized skin reports based on diagnostic modes of different skin shades and facial features

AI Skin Analyzer
Based on award-winning algorithms and patented technologies, EveLab Insight offers panoramic AI skin analyzers, a handheld skin analyzer and a photo-based skin analysis app.

SINGAPORE – December 13, 2022 – (Newswire.com)

Personalized skin care solutions have become the latest trend propelling the beauty industry into a new era. As consumers become more knowledgeable about their skin, they believe there is no one-size-fits-all skin care solution and that brands must tailor products to meet the specialized needs of each consumer. 

It is understood that the causes of skin problems are multifaceted. Genes, skin tone, living environment, etc., can affect the skin so the solutions should not be identical. Consumers’ access to knowledge about their skin is more varied than ever. According to research conducted by EveLab Insight, platforms such as YouTube and Instagram are consumers’ favorite channels for seeking skin care information as dermatologists are also popularizing skin-related knowledge on social media. With consumers’ knowledge of dermatology increasing, they tend to be more confident about their choices in skincare solutions.

Even though they are self-assured in skincare, skin needs to be diagnosed by dermatologists possessing expert insights into skin problems. However, there are barriers to accessing dermatologists due to financial reasons, geological barriers, and referral issues. Based on the same research, some family doctors only refer consumers to dermatologists if there are obvious skin problems. 

In response to consumers’ demand, EveLab Insight’s skin analysis system was developed. Based on years of dedication to deep-learning, artificial intelligence technology, and skin-related technology, EveLab Insight developed a handheld skin analyzer, an app-based skin analyzer, and AI skin analyzers to help consumers perform precise skin analysis anytime, anywhere. 

Eve M, the panoramic AI skin analyzer, is designed to generate personalized skin reports based on diagnostic modes of different skin shades and facial features. With EveLab Insight’s precise and stable algorithm, skin problems can be pinpointed and diagnosed. Ultimately, the system will automatically display the cause and solution in a user-friendly interface. In addition to skin concerns, the system also tells consumers their perceived age, skin type and tone compared to the average condition in EveLab Insight’s data bank, which helps consumers better understand their skin overall.

Beyond providing consumers with a more scientific way to understand their skin, EveLab Insight also aims to help beauty companies re-consolidate the trust between brands and consumers. As mentioned earlier, consumers have more access to dermatological knowledge and expect scientific validation of beauty solutions. The AI skin analyzer is a great tool to balance this situation. EveLab Insight has cooperated with global brands such as Dior, Shiseido, etc. In the future, we are looking forward to helping more brands build a symbiotic brand-consumer relationship.

Explore our website to learn more: www.evelabinsight.com.

Contact Information:

Daisy Zhang

Marketing Manager

[email protected]

Press Release Service
by
Newswire.com

Original Source:

In the Era of Various Skin Care Ideas, EveLab Insight Reveals the Ultimate Guide to Personalized Skin Care Through Science-Based Skin Analysis

SpendMend earns top honors for Recovery Auditing, for the second consecutive year, in the annual Corporate Excellence Awards

SpendMend SpendMend …